ទំព័រដើម › មហារីកស៊ុត › ប៉ែនស៊ីលវ៉ានី › Pittsburgh
ការសាកល្បងគ្លីនិកសម្រាប់ មហារីកស៊ុត នៅក្នុង Pittsburgh, PA
ការសិក្សាចំនួន 30 សម្រាប់ មហារីកស៊ុត កំពុងរកអ្នកចូលរួមនៅតាមទីតាំងក្នុង និងជុំវិញ Pittsburgh (ក្នុងចម្ងាយប្រហែល 30 ម៉ាយ)។ បើកការសិក្សាមួយដើម្បីមើលថាតើនរណាអាចចូលរួម និងរបៀបទំនាក់ទំនងទៅកាន់ក្រុមការងារសិក្សា។
អត្ថបទសិក្សាផ្លូវការ (អង់គ្លេស)
កំពុងរកអ្នកចូលរួមសម្រាប់ការសិក្សាមួយនៅទីនេះ? លេចធ្លោនៅផ្នែកខាងលើនៃទំព័រនេះ — $99 សម្រាប់ 30 ថ្ងៃ →
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
កំពុងជ្រើសរើសដំណាក់កាល 2/3
- UPMC Hillman Cancer Center, Pittsburgh
- UPMC-Passavant Hospital, Pittsburgh
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
កំពុងជ្រើសរើសដំណាក់កាល 2
- UPMC-Magee Womens Hospital, Pittsburgh
- UPMC Hillman Cancer Center, Pittsburgh
- UPMC-Passavant Hospital, Pittsburgh
- និង 3 ទៀត
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
កំពុងជ្រើសរើសដំណាក់កាល 1/2
- University of Pittsburgh Medical Center, Pittsburgh
Distance-Based Exercise to Preserve Function and Prevent Disability
កំពុងជ្រើសរើស
- UPMC Hillman Cancer Center, Pittsburgh
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
កំពុងជ្រើសរើសដំណាក់កាល 1
- Research Site, Pittsburgh
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
កំពុងជ្រើសរើសដំណាក់កាល 2
- Western Pennsylvania Gynecologic Oncology /ID# 278632, Pittsburgh
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
កំពុងជ្រើសរើសដំណាក់កាល 1/2
- Allegheny Health Network, Pittsburgh
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
កំពុងជ្រើសរើសដំណាក់កាល 3
- University of Pittsburgh Cancer Institute Cancer Services, Pittsburgh
- Allegheny Health Network- West Penn Hospital, Pittsburgh
Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
កំពុងជ្រើសរើសដំណាក់កាល 2
- University of Pittsburgh Medical Center, Magee-Womens Hospital, Pittsburgh
- West Penn Hospital of Allegheny Health Network, Pittsburgh
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
កំពុងជ្រើសរើសដំណាក់កាល 1/2
- Allegheny Singer, Pittsburgh
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
កំពុងជ្រើសរើសដំណាក់កាល 1/2
- Research Site, Pittsburgh
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
កំពុងជ្រើសរើសដំណាក់កាល 3
- Allegheny Health Network West Penn Hospital ( Site 0099), Pittsburgh
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
កំពុងជ្រើសរើសដំណាក់កាល 3
- AHN West Penn Hospital, Pittsburgh
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
កំពុងជ្រើសរើសដំណាក់កាល 1
- UPMC Hillman Cancer Center, Pittsburgh
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
កំពុងជ្រើសរើសដំណាក់កាល 1/2
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
កំពុងជ្រើសរើសដំណាក់កាល 1
- UPMC, Pittsburgh
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
កំពុងជ្រើសរើស
- Allegheny General Hospital, Pittsburgh
- UPMC-Magee Womens Hospital, Pittsburgh
- West Penn Hospital, Pittsburgh
- និង 5 ទៀត
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
កំពុងជ្រើសរើសដំណាក់កាល 1/2
- Allegheny Health Network, Pittsburgh
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
កំពុងជ្រើសរើសដំណាក់កាល 2
- 127, Pittsburgh
Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer
កំពុងជ្រើសរើសដំណាក់កាល 2
- Allegheny Health Network, Pittsburgh
An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib
កំពុងជ្រើសរើសដំណាក់កាល 2
- UPMC Magee-Women's Hospital, Pittsburgh
CPI-0209 Plus Carboplatin in Patients With Platinum Sensitive Recurrent Ovarian Cancer
កំពុងជ្រើសរើសដំណាក់កាល 1
- Magee-Womens Research Institute / UPMC Magee Womens Hospital, Pittsburgh
Lead-212 PSV359 Therapy for Patients With Solid Tumors
កំពុងជ្រើសរើសដំណាក់កាល 1/2
- University of Pittsburgh Medical Center, Pittsburgh
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
កំពុងជ្រើសរើសដំណាក់កាល 2
- University of Pittsburgh Medical Center, Pittsburgh
Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
កំពុងជ្រើសរើសដំណាក់កាល 1
- UPMC Hillman Cancer Center, Pittsburgh
A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Treated With Intravenously (IV) Infused Mirvetuximab Soravtansine
កំពុងជ្រើសរើសដំណាក់កាល 2
- Allegheny Health Network West Penn Hospital /ID# 272267, Pittsburgh
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
កំពុងជ្រើសរើសដំណាក់កាល 1/2
- University of Pittsburgh Medical Center, Pittsburgh
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
កំពុងជ្រើសរើសដំណាក់កាល 3
- West Penn Hospital, Pittsburgh
- Jefferson Hospital, Jefferson Hills · ឆ្ងាយ 11 ម៉ាយ
- Forbes Hospital, Monroeville · ឆ្ងាយ 11 ម៉ាយ
- និង 1 ទៀត
Heated Versus Aerosol-based Laparoscopic Chemotherapy for Cancer That Has Spread to the Peritoneum (Abdominal Lining)
កំពុងជ្រើសរើសដំណាក់កាល 2
- Allegheny Health Network West Penn Hospital, Pittsburgh
A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancers
កំពុងជ្រើសរើសដំណាក់កាល 1
- UPMC Hillman Cancer Center, Pittsburgh
ការសាកល្បងសម្រាប់ មហារីកស៊ុត នៅក្នុងទីក្រុងផ្សេងទៀត
- Houston, TXការសិក្សា 89
- New York City, NYការសិក្សា 69
- Boston, MAការសិក្សា 61
- Los Angeles, CAការសិក្សា 50
- Nashville, TNការសិក្សា 49
- Arlington, VAការសិក្សា 46
- Philadelphia, PAការសិក្សា 44
- Columbus, OHការសិក្សា 39
- St. Louis, MOការសិក្សា 38
- Chicago, ILការសិក្សា 36
- San Antonio, TXការសិក្សា 31
- Cleveland, OHការសិក្សា 30
ការសិក្សាផ្សេងទៀតនៅក្នុង Pittsburgh
- Non-Small Cell Lung Cancerការសិក្សា 48
- មហារីក (គ្រប់ប្រភេទ)ការសិក្សា 41
- មហារីកទ្រូងការសិក្សា 39
- មហារីកពោះវៀនធំ និងទ្វារមាសការសិក្សា 32
- មហារីកដែលរីករាលដាលការសិក្សា 31
- មេឡាណូម៉ាការសិក្សា 31
- មហារីកស្រទាប់ស្បែកស្តីការសិក្សា 23
- មហារីកតូចការសិក្សា 23
- មហារីកសួតការសិក្សា 23
- មហារីកកោសិកាស្រអាប់នៅក្បាល និងបំបៅកការសិក្សា 22
- ជំងឺគ្រុនចាញ់ការសិក្សា 22
- ភាពសោកសៅការសិក្សា 22
ពី ClinicalTrials.gov, ទិន្នន័យទទួលបាននៅថ្ងៃ 6 តុលា 2026។ ការសិក្នានីមួយៗកំណត់លក្ខខណ្ឌលក្ខណៈសម្បត្តិរបស់ខ្លួន; ក្រុមការងារសិក្សាកំណត់ថាតើនរណាអាចចូលរួម។